Omeros (OMER) Prepaid Assets (2010 - 2026)
Omeros (OMER) posted Prepaid Assets of $7.3 million for Q1 2026, down 3.27% sequentially from $7.6 million in Q4 2025, and down 1.61% YoY from $7.5 million in Q1 2025.
Analysis
Omeros (OMER) Prepaid Assets (2010 - 2026) Analysis & Trends
Omeros has reported Prepaid Assets for 17 years, with the latest figure at $7.3 million in Q1 2026.
- Quarterly Prepaid Assets fell 1.61% year-over-year to $7.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.3 million (down 1.61% YoY) and the FY2025 annual result came in at $7.6 million, up 5.99% from the prior year.
- Prepaid Assets fell to $7.3 million in Q1 2026 per OMER's latest filing, from $7.6 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $13.5 million in Q1 2024 and troughed at $3.8 million in Q3 2025.
- A 5-year average of $7.3 million and a median of $7.0 million in 2023 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2024 and 2025: Prepaid Assets surged 100.7% in 2024, then sank 44.54% in 2025.
- Over 5 years, Prepaid Assets stood at $6.3 million in 2022, then surged by 36.21% to $8.6 million in 2023, then dropped by 16.49% to $7.2 million in 2024, then climbed by 5.99% to $7.6 million in 2025, then slipped by 3.27% to $7.3 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $7.3 million, $7.6 million, and $3.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Omeros | 1.38 Bn | 1.38 Bn | 27.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.54 Mn |
| Mar 31, 2026 | 7.35 Mn |
| Dec 31, 2025 | 7.60 Mn |
| Sep 30, 2025 | 3.76 Mn |
| Jun 30, 2025 | 6.41 Mn |
| Mar 31, 2025 | 7.47 Mn |
| Dec 31, 2024 | 7.17 Mn |
| Sep 30, 2024 | 6.13 Mn |
| Jun 30, 2024 | 6.27 Mn |
| Mar 31, 2024 | 13.46 Mn |
| Dec 31, 2023 | 8.58 Mn |
| Sep 30, 2023 | 4.92 Mn |
| Jun 30, 2023 | 7.00 Mn |
| Mar 31, 2023 | 6.71 Mn |
| Dec 31, 2022 | 6.30 Mn |
| Sep 30, 2022 | 5.98 Mn |
| Jun 30, 2022 | 11.89 Mn |
| Mar 31, 2022 | 7.62 Mn |
| Dec 31, 2021 | 8.22 Mn |
| Sep 30, 2021 | 6.37 Mn |